Dr. Carola Schipke (CSO)

Dr. Carola Schipke is a trained biochemist with many years of experience in the development of biomarkers for Alzheimer's disease as well as in the scientific supervision of clinical trials. In her many years of professional activity in this field, she has built a network with fellow researchers both in the academic field as well as in international companies.

Throughout her career she has worked closely with both life science companies and research groups worldwide. Her work has been documented in well over 20 publications in international peer-reviewed journals.

Felix Menne

Felix Menne has a degree in psychology and worked as study coordinator and clinical psychologist at the Charité university hospital Berlin before starting as Clinical Trial Manager for Predemtec. At the Charité, he was responsible in particular for the implementation and organization of the publicly funded studies of the German Center for Neurodegenerative Diseases (DZNE), in which patients with various neurodegenerative diseases such as Alzheimer's disease are observed in long-term studies. He has also been involved in conducting clinical trials in collaboration with pharmaceutical companies such as Novartis or Roche, as well as in unicentric scientific projects at the Charité.